Stock Under $10 with 50-100% upside potential - 14 Days FREE!
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Dow Today: Home Depot (HD) Leads The Day Higher, Pfizer (PFE) Lags

The Dow Jones Industrial Average (^DJI) is trading down 18.0 points (-0.1%) at 13,189 as of Monday, Aug 13, 2012, 9:35 a.m. ET. During this time, 15.9 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 661.9 million. The NYSE advances/declines ratio sits at 1,157 issues advancing vs. 1,504 declining with 167 unchanged.

The Dow component leading the way higher looks to be Home Depot (NYSE:HD), which is sporting a nine-cent gain (+0.2%) bringing the stock to $53.15. Volume for Home Depot currently sits at 355,144 shares traded vs. an average daily trading volume of 11.7 million shares.

Home Depot has a market cap of $80.8 billion and is part of the services sector and retail industry. Shares are up 25.6% year to date as of Friday's close. The stock's dividend yield sits at 2.2%.

The Home Depot, Inc., together with its subsidiaries, operates as a home improvement retailer. The company's stores sell building materials, and home improvement and lawn and garden products to do-it-yourself, do-it-for-me (at D-I-F-M), and professional customers. The company has a P/E ratio of 20.1, equal to the average retail industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Home Depot as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated.

Holding back the Dow today is Pfizer (NYSE:PFE), which is lagging the broader Dow index with a 20-cent decline (-0.8%) bringing the stock to $23.74. This single loss is lowering the Dow Jones Industrial Average by 1.51 points or roughly accounting for 8.4% of the Dow's overall loss. Volume for Pfizer currently sits at 1.3 million shares traded vs. an average daily trading volume of 34.6 million shares.

Pfizer has a market cap of $178.44 billion and is part of the health care sector and drugs industry. Shares are up 10.1% year to date as of Friday's close. The stock's dividend yield sits at 3.7%.

Pfizer Inc., a biopharmaceutical company, engages in the discovery, development, manufacture, and sale of medicines for people and animals worldwide. The company has a P/E ratio of 20.2, above the average drugs industry P/E ratio of 17.7 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Pfizer as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,294.50 -12.67 -0.08%
NASDAQ 3,459.42 -3.88 -0.11%
S&P 500 1,650.51 -4.84 -0.29%
US 10 Yr 2.023% -0.003

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs